Claros Diagnostics Raises $4 Million

Claros Diagnostics Inc., a Woburn, Mass.-based developer of handheld urological cancer diagnostic testing systems for point-of-care use, has raised $4 million in second-round funding, according to a regulatory filing. Shareholders include Oxford Bioscience Partners, Bioventures Investors, Accelerated Technologies Partners and Commons Capital. www.clarosdx.com

Leave a Reply

PE HUB Community

Join the 12518 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget